According to the documents obtained by the Times-Union, the kidney transplant program had falling survival rates, breaches to its own “adverse events” policy and numerous record-keeping errors in which some patients were not eligible for a kidney transplant.
Shands Jacksonville officials, however, stated that the closing of the program was based on low patient volumes. Emails obtained by the Times-Union showed that hospital officials had misled media and did not disclose the program’s performance and record problems.
Read the entire Florida Times-Union report on the Shands Jacksonville Medical Center transplant program.
Related Articles on Transplant Issues:
Study: Time of Day May Not Affect Patient Survival Rate for Heart, Lung Transplants
UPMC Surgeon, Nurse Disciplined for Transplanting Kidney From Donor With Hepatitis C
Pennsylvania Health Department: Temple University Hospital Fails to Meet Federal Requirements for Transplants
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
